Risicoverevening Policy Updates: Key Amendments...

By HEOR Staff Writer

January 27, 2026

On December 9, 2025, the Board of Directors of Zorginstituut Nederland (decision reference 2025027072) approved amendments to the Beleidsregels risicoverevening for 2022, 2023, 2024, and 2025. These changes, published in Staatscourant...
Johnson & Johnson’s Medicine Access Agreement: Paving the Way for ...
Novartis Drug Pricing Agreement
INFARMED Leadership Appointments: A New Era in Health Regulation and Expertise
Advancements in Continuous Glucose Monitoring for Type 2 Diabetes Management
Shifting Toward Sustainable Reimbursement Models in South Africa’s Heal...
Medical Schemes Affordability Crisis: Insights from the CMS Annual Report 202...
Aligning Medical Schemes with National Health Insurance South Africa
Rethinking Health Technology Assessment: Evolving Economic Evaluations for Fa...
PhRMA’s Patient Access Investment: $500 Billion Commitment to Domestic ...
Sanofi Insulin Savings: Your Comprehensive Guide for 2025
NHS Productivity Gains at Risk: Balancing Innovation and Cost Control
Medicare ACO Outcomes: Balancing Surgical Benefits and Costs Under the TEAM M...